List of Excipients in API PENTOBARBITAL SODIUM
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing PENTOBARBITAL SODIUM
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Akorn | pentobarbital sodium | 17478-181 | ALCOHOL |
| Akorn | pentobarbital sodium | 17478-181 | HYDROCHLORIC ACID |
| Akorn | pentobarbital sodium | 17478-181 | PROPYLENE GLYCOL |
| Akorn | pentobarbital sodium | 17478-181 | SODIUM HYDROXIDE |
| Akorn | pentobarbital sodium | 17478-181 | WATER |
| Hikma Pharmaceuticals USA Inc (dba Leucadia Pharmaceuticals) | pentobarbital sodium | 24201-010 | ALCOHOL |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for PENTOBARBITAL SODIUM
Excipient focus: ALCOHOL
PENTOBARBITAL SODIUM drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Akorn | pentobarbital sodium | 17478-181 |
| Hikma Pharmaceuticals USA Inc (dba Leucadia Pharmaceuticals) | pentobarbital sodium | 24201-010 |
| Sagent Pharmaceuticals | pentobarbital sodium | 25021-676 |
| Akron | pentobarbital sodium | 76478-501 |
| >Company | >Ingredient | >NDC |
PENTOBARBITAL SODIUM drug variants not containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
PENTOBARBITAL SODIUM drug variants containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Akorn | pentobarbital sodium | 17478-181 |
| Sagent Pharmaceuticals | pentobarbital sodium | 25021-676 |
| Akron | pentobarbital sodium | 76478-501 |
| >Company | >Ingredient | >NDC |
PENTOBARBITAL SODIUM drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc (dba Leucadia Pharmaceuticals) | pentobarbital sodium | 24201-010 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
PENTOBARBITAL SODIUM drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Akorn | pentobarbital sodium | 17478-181 |
| Hikma Pharmaceuticals USA Inc (dba Leucadia Pharmaceuticals) | pentobarbital sodium | 24201-010 |
| Sagent Pharmaceuticals | pentobarbital sodium | 25021-676 |
| Akron | pentobarbital sodium | 76478-501 |
| >Company | >Ingredient | >NDC |
PENTOBARBITAL SODIUM drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
PENTOBARBITAL SODIUM drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Akorn | pentobarbital sodium | 17478-181 |
| Sagent Pharmaceuticals | pentobarbital sodium | 25021-676 |
| Akron | pentobarbital sodium | 76478-501 |
| >Company | >Ingredient | >NDC |
PENTOBARBITAL SODIUM drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc (dba Leucadia Pharmaceuticals) | pentobarbital sodium | 24201-010 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
PENTOBARBITAL SODIUM drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Akorn | pentobarbital sodium | 17478-181 |
| Hikma Pharmaceuticals USA Inc (dba Leucadia Pharmaceuticals) | pentobarbital sodium | 24201-010 |
| Sagent Pharmaceuticals | pentobarbital sodium | 25021-676 |
| Akron | pentobarbital sodium | 76478-501 |
| >Company | >Ingredient | >NDC |
PENTOBARBITAL SODIUM drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
